iRhythm Technologies Inc (IRTC)
iRhythm Technologies Announces Third Quarter 2025 Financial Results
Veeva Systems Inc (VEEV)
Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025
DexCom Inc (DXCM)
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
Gilead Sciences Inc (GILD)
Gilead Sciences Announces Third Quarter 2025 Financial Results
Mind Medicine (MNMD)
MindMed to Report Q3 2025 Financial Results on November 6, 2025
Sangamo Therapeutics Inc (SGMO)
Sangamo Therapeutics Announces Third Quarter 2025 Earnings Call
Ardelyx Inc. (ARDX)
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Ligand Pharmaceuticals Incorporated (LGND)
Ligand to Participate in November Investor Conferences
Celldex Therapeutics Inc. (CLDX)
Celldex Announces Initial Positive Results from Phase 1 Trial of CDX-622 Demonstrating Favorable Safety and PK Profile and Sustained Mast Cell Inhibition
Travere Therapeutics, Inc (TVTX)
Travere Therapeutics Reports Third Quarter 2025 Financial Results